Clinical Trials Logo

Acetaminophen Exposure clinical trials

View clinical trials related to Acetaminophen Exposure.

Filter by:
  • None
  • Page 1

NCT ID: NCT02911961 Recruiting - Clinical trials for Acetaminophen Exposure

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Start date: June 2021
Phase: Phase 4
Study type: Interventional

The objective of this study is to provide preliminary data to describe serum acetaminophen-cysteine protein adduct (APAP-CYS) concentrations following therapeutic doses of acetaminophen in the setting of non-acetaminophen induced liver injury. This study will utilize hepatic embolization as a model of hepatic injury.